New research seems to show the potential of a CRISPR-based gene therapy meant to neuter certain forms of cardiovascular disease. In the world’s first human trial of the therapy, people given the highest doses experienced significant and long-lasting reductions in their low-density lipoprotein cholesterol (LDL-C). The…
New research seems to show the potential of a CRISPR-based gene therapy meant to neuter certain forms of cardiovascular disease. In the world’s first human trial of the therapy, people given the highest doses experienced significant and long-lasting reductions in their low-density lipoprotein cholesterol (LDL-C). The…Read more… Read More gene therapy, cholesterol, familial hypercholesterolemia, health medical pharma, alirocumab, lipid metabolism disorders, hypercholesterolemia, lipoproteins, eli lilly, low density lipoprotein, verve 101, verve therapeutics, pcsk9, andrew bellinger, lipid lowering agent, cardiology Gizmodo
